Cytokinetics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +11.3% | -2.0% | +88.6% | -5.8% | -2.4% | -9.8% | -3.0% | +17.2% | -0.8% | -10.6% | +51.1% | |
| – | +11.9% | +1.7% | +67.2% | -4.6% | +8.8% | -13.7% | -7.3% | +10.2% | -6.2% | -8.5% | +44.0% | |
| – | +13.7% | +5.8% | +58.8% | -75.4% | +102.3% | -22.3% | +1.7% | +200.9% | -45.7% | +6.0% | +96.6% | |
| – | +14.1% | +0.6% | +70.8% | -4.3% | +6.4% | -12.8% | -8.5% | +12.2% | -8.3% | -7.2% | +42.4% | |
| – | -48.7% | -35.0% | -100.0% | – | +6,723.8% | -87.9% | +318.0% | -78.5% | +882.5% | -61.6% | +257.9% | |
| – | – | – | – | – | – | – | – | – | – | – | +146.8% | |
| – | +2.6% | -0.5% | +17.5% | +2.5% | +6.0% | -0.4% | +4.2% | +22.8% | +6.5% | +0.8% | -0.1% | |
| – | +32.1% | -13.5% | +15.7% | +6.8% | +63.6% | -11.1% | -17.9% | +8.5% | +42.4% | -1.6% | -8.9% | |
| – | +62.3% | +6.4% | +0.9% | +1.2% | +0.4% | +6.7% | +4.5% | +11.6% | +59.0% | +9.1% | -26.4% | |
| – | +55.9% | -39.7% | -27.0% | +22.3% | +75.9% | -31.6% | +16.4% | +36.1% | +1.1% | +10.6% | -17.0% | |
| – | -0.3% | -0.1% | +6.1% | +0.2% | +0.2% | -0.1% | +10.5% | +47.0% | +6.5% | +0.2% | +0.2% | |
| – | – | – | – | -112.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.1% | +2.9% | +7.2% | +7.7% | +0.3% | +0.4% | +0.8% | +0.4% | +2.0% | +0.7% | +7.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.